ursodeoxycholic acid has been researched along with Chronic Disease in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (6.25) | 18.7374 |
1990's | 61 (54.46) | 18.2507 |
2000's | 19 (16.96) | 29.6817 |
2010's | 22 (19.64) | 24.3611 |
2020's | 3 (2.68) | 2.80 |
Authors | Studies |
---|---|
Fickert, P; Wagner, M | 1 |
Battezzati, PM; Buuren, HRV; Corpechot, C; de Veer, RC; Floreani, A; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Pares, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, AJ | 1 |
Alberca-Páramo, A; Estaire-Gómez, M; Fernández, JM; García-Santos, EP; Padilla-Valverde, D; Villarejo-Campos, P | 1 |
Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E | 1 |
Debray, D; Gonzales, E; Thébaut, A | 1 |
Ashby, D; Cheng, K; Smyth, RL | 3 |
Jansen, PLM | 1 |
Coffey, A; Leung, DH; Quintanilla, NM | 1 |
Düll, MM; Kremer, AE | 1 |
Floreani, A; Grattagliano, I; Portincasa, P; Ubaldi, E | 1 |
Boyer, JL; Cai, SY; Mennone, A; Soroka, CJ | 1 |
Bachmeyer, C; Girot, R; Moguelet, P; Rein, C | 1 |
Ali, AH; Carey, EJ; Lindor, KD; Tabibian, JH | 1 |
Biswal, N; Chandrasekaran, V; Jagadisan, B; Nair, VS | 1 |
Matanina, NV; Reĭzis, AR | 1 |
Krok, KL; Munoz, SJ | 1 |
Boggia, B; Buonpensiero, P; De Gregorio, F; Di Pasqua, A; Ferri, P; Raia, V; Sepe, A; Siano, M | 1 |
Paumgartner, G | 2 |
Eisendle, K; Graziadei, I; Höpfl, R; Müller, H; Ortner, E; Talasz, H; Vogel, W | 1 |
Golovanova, EV; Petrakov, AV | 1 |
Golovanova, EV; Noskova, KK; Petrakov, AV | 1 |
Fauler, G; Fickert, P; Frank, S; Guelly, C; Gumhold, J; Höfler, G; Kratky, D; Lass, A; Magnes, C; Moustafa, T; Reicher, H; Sattler, W; Silbert, D; Sinner, F; Thueringer, A; Trauner, M; Zechner, R | 1 |
Fang, LJ; Knisely, AS; Liu, LY; Lu, Y; Wang, JS; Wang, XH; Yu, H | 1 |
Bjelakovic, G; Gluud, C; Krstic, MN; Poropat, G; Rudic, JS | 1 |
Himeno, S; Kanayama, Y; Katoh, T; Kiriyama, K; Manabe, N; Matsushima, N; Shizusawa, T; Taniguchi, M; Tsubakio, K; Yabu, M | 1 |
Bernard, B; Cadranel, JF; Di Martino, V; Dorent, R; Gandjbakhch, I; Ghoussoub, JJ; Grippon, P; Hoang, C; Huraux, JM; Lunel, F; Myara, A; Opolon, P; Pauwels, A; Perrin, M; Thabut, D; Trivin, F | 1 |
Beuers, U; Dilger, K; Hempfling, W | 1 |
Okazaki, K | 1 |
Borras, C; Carretero, J; Cutrin, J; Pallardó, FV; Pereda, J; Poli, G; Sastre, J; Serviddio, G; Vendemiale, G; Viña, J | 1 |
Koyama, M; Kunisaki, Y; Matsue, K; Matsuoka, K; Takeuchi, M | 1 |
Borges, DR; de J Ribeiro, P; de Toledo, CF; Narciso, JL | 1 |
Miescher, G; Paumgartner, G; Preisig, R | 1 |
Buffet, C; Chaput, JC; Etienne, JP; Franco, D; Houssin, D; Labayle, D | 1 |
Hirota, K; Ito, Y; Ohto, M; Omata, M; Takano, S; Uchiumi, K; Yokosuka, O | 1 |
Imazeki, F; Omata, M; Yokosuka, O | 1 |
Annovazzi, G; Filippi, T; Magrini, A; Pannullo, A; Puoti, C | 2 |
Kimura, A; Makino, I; Nakamura, K | 1 |
Andre, P; Boucher, E; Brissot, P; Deugnier, Y; Guyader, D; Jacquelinet, C; Jouanolle, H; Moirand, R; Ruffault, A; Turlin, B | 1 |
Angelico, M; Baroni, CD; Bini, A; Capocaccia, L; Del Vecchio, C; Gandin, C; Pescarmona, E; Rapicetta, M; Spada, E | 1 |
Akiyama, K; Makino, I; Nakamura, K | 1 |
Leuschner, U | 1 |
Enomoto, M; Sadamoto, T; Sato, G; Shibata, M; Tuzimoto, S; Ueno, Y; Watanabe, M; Yamagami, T; Yasushi, T | 1 |
Balan, V; Dickson, ER; Jorgensen, RA; Lindor, KD | 1 |
Luketic, VA; Sanyal, AJ | 1 |
Cirillo, NW; Zwas, FR | 1 |
Jaffe, PE | 1 |
Balladur, P; Cogliandolo, A; Coutris, G; de Saint-Laurent, J; Hannoun, L; Hecht, Y; Kieffel, T; Nordlinger, B; Parc, R; Vaubourdolle, M | 1 |
Kurtz, W; Schmeck-Lindenau, HJ | 1 |
Carughi, S; Lucentini, L; Sperandeo, G; Sperandeo, M; Varriale, A | 1 |
Beuers, U; Paumgartner, G; Sauter, G | 1 |
Lacaille, F | 1 |
Parés, A; Rodés, J | 1 |
Anderson, ML; Gores, GJ; Hofmann, AF; Jorgensen, RA; LaRusso, NF; Lindor, KD | 1 |
Masuda, T; Nakadate, I; Sato, S; Suzuki, K; Yamazaki, K | 1 |
Goeser, T; Mohler, M; Seipp, S; Stremmel, W; Theilmann, L; Tox, U | 1 |
O'Brien, CB; Reddy, KR; Saul, SH; Shields, DS | 1 |
Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H | 1 |
Aoshima, M; Fujita, M; Hasegawa, T; Kato, T; Kimura, A; Makino, I; Nakamura, K; Saito, H; Sato, Y; Tamori, K; Yokohama, S; Yoneda, M | 1 |
Crosignani, A; Invernizzi, P; Larghi, A; Podda, M; Rodrigues, CM; Setchell, KD | 1 |
Imai, Y; Inui, Y; Ito, N; Kawata, S; Kiso, S; Matsuzawa, Y; Tamura, S | 1 |
Schimanski, U; Stiehl, A; Stremmel, W; Theilmann, L | 1 |
Färkkilä, M; Kahri, A; Koivisto, T; Nieminen, U | 1 |
Chazouillères, O; Haniche, M; Jian, R; Marteau, P; Poupon, R | 1 |
Arata, S; Ikeda, M; Kitamura, T; Kondo, M; Morimoto, M; Saito, S; Sakaguchi, T; Sekihara, H; Tanaka, K | 1 |
Bruguera, M | 1 |
Arndt, H; Benda, W; Gross, V; Kullmann, F; Rüschoff, J; Schölmerich, J; Winkler von Mohrenfels, A | 1 |
Saksena, S; Tandon, RK | 1 |
Attar, A; Aubertin, JM; Bécheur, H; Bloch, F; Charton-Bain, MC; Chatellier, G; Dall'osto, H; Petite, JP | 1 |
Junge, U; Pohl, R | 1 |
Balò, S; Clerici, C; Distrutti, E; Gentili, G; Giansanti, M; Miglietti, M; Morelli, A; Morselli-Labate, AM; Rusticali, AG; Solinas, A | 1 |
Librant-Suska, M; Warunek, W; Zejc-Bajsarowicz, M | 1 |
Fiedler, GM; Grunewald, RW; Müller, GA; Schauer, A; Stöckmann, F | 1 |
Hay, JE | 1 |
Amital, H; Bar-Dayan, Y; Gershwin, ME; Levi, Y; Shoenfeld, Y | 1 |
Graziadei, IW; Trauner, M | 1 |
Beuers, U; Büttner, J; Kullak-Ublick, GA; Oswald, M; Paumgartner, G; Rust, C; Sauter, GH | 1 |
Chazouillères, O; Poupon, R; Poupon, RE | 1 |
Kowdley, KV | 1 |
Sokol, RJ | 1 |
Kumar, D; Tandon, RK | 1 |
Sanyal, A | 1 |
Chayama, K; Tazuma, S | 1 |
Gatzen, M; Pausch, J | 1 |
Linares Rodríguez, A | 1 |
Lirussi, F; Okolicsanyi, L | 2 |
Jávor, T; Pár, A; Patty, I; Vincze, A | 1 |
Chazalette, JP; Figarella, C; Galabert, C; Lecuire, A; Lengrand, D; Montet, JC; Sotta, C | 1 |
Buffarini, F; Novelli, V; Orsini, M; Parini, P; Pinto, A; Roda, E; Salzetta, A; Sangermano, A; Zagari, M | 1 |
Buongiorno, G; Guerra, V; Manghisi, OG; Misciagna, G; Quaranta, GM | 1 |
Fisher, LD; Fried, RH; McDonald, GB; Murakami, CS; Sullivan, KM; Willson, RA | 1 |
Beuers, U; Fischer, S; Pauletzki, J; Paumgartner, G; Spengler, U; Zwiebel, FM | 1 |
Hofmann, AF | 1 |
Reichen, J | 1 |
Calmus, Y; Poupon, R | 1 |
de Caestecker, JS; Jazrawi, RP; Northfield, TC; Petroni, ML | 1 |
van Berge Henegouwen, GP; van Erpecum, KJ | 1 |
Beuers, U | 1 |
Beuers, U; Paumgartner, G; Richter, WO; Ritter, MM | 1 |
James, OF | 1 |
Bateson, MC | 1 |
Cotting, J; Lentze, MJ; Reichen, J | 1 |
Mansurov, KhKh | 1 |
Battezzati, PM; Bertolini, E; Crosignani, A; Ghezzi, C; Petroni, ML; Podda, M; Zuin, M | 1 |
Hayakawa, T; Hoshino, M; Katagiri, K; Kawamura, Y; Miyani, M; Nakai, T; Ohnishi, H; Shiraka, S; Takeshima, A; Tsukada, K | 1 |
Ban, N; Kawasaki, T; Kimura, T; Moriyasu, F; Nakamura, T; Ono, S; Tamada, T; Uchino, H; Yamashita, Y | 1 |
Luciani, A; Massari, M; Montanari, P; Nora, A; Zandomeneghi, R | 1 |
43 review(s) available for ursodeoxycholic acid and Chronic Disease
Article | Year |
---|---|
Drug Therapies for Chronic Cholestatic Liver Diseases.
Topics: Animals; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Disease Progression; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2020 |
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
[Physiopathology and management of cholestatic pruritus in children].
Topics: Anion Exchange Resins; Biliary Tract Surgical Procedures; Child; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Cytochrome P-450 CYP3A Inducers; Humans; Liver Transplantation; Narcotic Antagonists; Pruritus; Rifampin; Selective Serotonin Reuptake Inhibitors; Sertraline; Sorption Detoxification; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Nutritional Status; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
New therapies target the toxic consequences of cholestatic liver disease.
Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Chronic Disease; Humans; Organic Anion Transporters, Sodium-Dependent; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Symporters; Ursodeoxycholic Acid | 2018 |
Management of Chronic Hepatic Itch.
Topics: Analgesics, Opioid; Anion Exchange Resins; Antipruritics; Bezafibrate; Carrier Proteins; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Cytochrome P-450 Enzyme Inducers; Drainage; Humans; Hypolipidemic Agents; Membrane Glycoproteins; Methylamines; Narcotic Antagonists; Prevalence; Pruritus; Rifampin; Thiazepines; Ursodeoxycholic Acid | 2018 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Adolescent; Adult; Bile; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2014 |
Emerging drugs for the treatment of Primary Biliary Cholangitis.
Topics: Alkaline Phosphatase; Animals; Autoantibodies; Cholangitis; Chronic Disease; Disease Progression; Drug Design; Female; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Male; Mitochondria; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Topics: Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2012 |
Ursodeoxycholic acid for primary biliary cirrhosis.
Topics: Administration, Oral; Cause of Death; Cholagogues and Choleretics; Chronic Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2012 |
Systematic review: ursodeoxycholic acid--adverse effects and drug interactions.
Topics: Cholagogues and Choleretics; Chronic Disease; Drug Interactions; Female; Humans; Liver Diseases; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2003 |
[Therapy for chronic pancreatitis and the prognosis].
Topics: Abdominal Pain; Alcohol Drinking; Autoimmune Diseases; Chronic Disease; Drainage; Gallstones; Histamine H2 Antagonists; Humans; Lithotripsy; Pancreatic Ducts; Pancreatitis; Prednisolone; Pressure; Prognosis; Protease Inhibitors; Ursodeoxycholic Acid | 2004 |
Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.
Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Cholestasis, Intrahepatic; Chronic Disease; Hepatocytes; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2006 |
[Bile acids in therapy of liver diseases].
Topics: Chronic Disease; Dose-Response Relationship, Drug; Humans; Liver Diseases; Ursodeoxycholic Acid | 1994 |
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
Topics: Alagille Syndrome; Biliary Atresia; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid in the treatment of chronic liver disease.
Topics: Chronic Disease; Clinical Trials as Topic; Cystic Fibrosis; Hepatitis, Chronic; Humans; Liver Diseases; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 1994 |
Gallstones. Who are good candidates for nonsurgical treatment?
Topics: Acute Disease; Administration, Oral; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Chenodeoxycholic Acid; Cholecystitis; Cholecystostomy; Cholelithiasis; Chronic Disease; Ethers; Female; Humans; Instillation, Drug; Lithotripsy; Male; Methyl Ethers; Obesity; Recurrence; Risk Factors; Sex Factors; Solvents; Ursodeoxycholic Acid | 1993 |
[The therapy of intrahepatic cholestasis].
Topics: Cholestasis, Intrahepatic; Chronic Disease; Combined Modality Therapy; Humans; Liver Transplantation; Ursodeoxycholic Acid | 1993 |
[Bile acids in the therapy of chronic liver diseases].
Topics: Chronic Disease; Hepatitis, Chronic; Humans; Liver Diseases; Ursodeoxycholic Acid | 1993 |
[Bile acids and their therapeutic use in children].
Topics: Adult; Animals; Bile Acids and Salts; Cell Membrane; Child; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Cystic Fibrosis; Humans; Immunosuppressive Agents; Ursodeoxycholic Acid | 1995 |
[Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Female; Graft vs Host Disease; Hepatitis; Hepatitis, Alcoholic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 1996 |
Drug-induced vanishing bile duct syndrome: response to ursodiol.
Topics: Antipsychotic Agents; Bile Duct Diseases; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Female; Humans; Liver Function Tests; Middle Aged; Prochlorperazine; Syndrome; Ursodeoxycholic Acid | 1996 |
Clinical pharmacokinetics of therapeutic bile acids.
Topics: Absorption; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Chronic Disease; Humans; Injections, Intravenous; Liver; Liver Diseases; Ursodeoxycholic Acid | 1996 |
[Treatment of chronic hepatitis C: still many problems pending].
Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cholagogues and Choleretics; Chronic Disease; Clinical Enzyme Tests; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Indomethacin; Interferons; Ofloxacin; Phlebotomy; Recurrence; Ribavirin; Time Factors; Ursodeoxycholic Acid | 1997 |
Ursodeoxycholic acid in the treatment of liver diseases.
Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Chronic Disease; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Diseases; Liver Transplantation; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
[Use of ursodeoxycholic acid in treatment of chronic hepatitis C].
Topics: Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Remission Induction; Ursodeoxycholic Acid | 1996 |
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Chronic Disease; Endoscopy; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Patient Selection; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1998 |
Primary biliary cirrhosis. Is (and how much of) the pathology preventible?
Topics: Antibodies; Antibody Specificity; Autoimmune Diseases; Biomarkers; Cholagogues and Choleretics; Chronic Disease; Disease Progression; Humans; Liver Cirrhosis, Biliary; Mitochondria; Risk Factors; Ursodeoxycholic Acid | 1998 |
Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
Topics: Animals; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Liver Diseases; Pregnancy; Ursodeoxycholic Acid | 1999 |
Chronic cholestatic diseases.
Topics: Adult; Anti-Inflammatory Agents; Child, Preschool; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Humans; Immunosuppressive Agents; Liver Transplantation; Ursodeoxycholic Acid | 2000 |
Ursodeoxycholic acid therapy in hepatobiliary disease.
Topics: Biliary Tract Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2000 |
Use of ursodeoxycholic acid in liver diseases.
Topics: Cholagogues and Choleretics; Chronic Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 2001 |
Treatment of cholestasis and cholestatic disorders.
Topics: Cholagogues and Choleretics; Cholestasis; Chronic Disease; Humans; Ursodeoxycholic Acid | 2001 |
[Treatment of cholestatic liver diseases].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Controlled Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant, Newborn; Liver Cirrhosis, Biliary; Male; Prednisolone; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 2002 |
[Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Topics: Adjuvants, Immunologic; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2000 |
Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
Topics: Bile Acids and Salts; Cell Membrane; Cholestasis, Intrahepatic; Chronic Disease; Hepatitis, Chronic; Humans; In Vitro Techniques; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1992 |
[Drug treatment of cholestatic liver diseases].
Topics: Cholestasis, Intrahepatic; Chronic Disease; Colchicine; Humans; Immunosuppressive Agents; Liver Transplantation; Penicillamine; S-Adenosylmethionine; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases.
Topics: Animals; Cholestasis; Chronic Disease; Histocompatibility Antigens Class I; Humans; In Vitro Techniques; Liver Cirrhosis, Biliary; Major Histocompatibility Complex; Ursodeoxycholic Acid | 1991 |
Ursodeoxycholic acid in chronic liver disease.
Topics: Animals; Cholestasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1991 |
[Bile acid therapy; new hope for patients with chronic liver diseases].
Topics: Cholangitis, Sclerosing; Cholelithiasis; Chronic Disease; Hepatitis, Chronic; Humans; Infant, Newborn; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Ursodeoxycholic Acid | 1991 |
Ursodeoxycholic acid treatment for chronic cholestatic liver disease.
Topics: Cholestasis, Intrahepatic; Chronic Disease; Deoxycholic Acid; Humans; Ursodeoxycholic Acid | 1990 |
[Prevention of cholelithiasis].
Topics: Benzhydryl Compounds; Bile; Bile Acids and Salts; Chemical Phenomena; Chemistry, Physical; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Chronic Disease; Dietary Fiber; Female; Humans; Male; Time Factors; Ursodeoxycholic Acid; USSR | 1985 |
Ursodeoxycholic acid for chronic liver diseases.
Topics: Chronic Disease; Clinical Trials as Topic; Deoxycholic Acid; Hepatitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1988 |
18 trial(s) available for ursodeoxycholic acid and Chronic Disease
Article | Year |
---|---|
[Peripheral blood lymphocyte apoptosis in children with viral hepatites A, B, C and effect of ursodeoxycholic acid preparations].
Topics: Acute Disease; Adolescent; Apoptosis; Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Flow Cytometry; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Lymphocytes; Ursodeoxycholic Acid | 2008 |
Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Bile Acids and Salts; Cholagogues and Choleretics; Chronic Disease; Double-Blind Method; Female; gamma-Glutamyltransferase; Heart Transplantation; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Viral, Human; Humans; Liver; Male; Middle Aged; Placebos; Ursodeoxycholic Acid | 2003 |
A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C.
Topics: Alanine Transaminase; Bile Acids and Salts; Chronic Disease; Dose-Response Relationship, Drug; Female; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Humans; Liver; Male; Middle Aged; Osmolar Concentration; RNA; Ursodeoxycholic Acid | 1994 |
Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients.
Topics: Adult; Alanine Transaminase; Base Sequence; Biopsy; Chronic Disease; Clinical Protocols; Combined Modality Therapy; Female; Follow-Up Studies; gamma-Glutamyltransferase; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Molecular Sequence Data; Recombinant Proteins; RNA, Viral; Ursodeoxycholic Acid | 1995 |
Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Probability; Recombinant Proteins; Recurrence; Regression Analysis; Treatment Outcome; Ursodeoxycholic Acid | 1995 |
[Effect of long-term ursodeoxycholic acid treatment on serum liver enzymes and serum bile acid metabolism in chronic hepatitis].
Topics: Aged; Bile Acids and Salts; Chronic Disease; Female; Hepatitis; Hepatitis B; Hepatitis C; Humans; Liver; Liver Function Tests; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 1995 |
Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.
Topics: Adult; Bilirubin; Cholesterol; Cholesterol, HDL; Chronic Disease; Female; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Triglycerides; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid and chronic hepatitis C infection.
Topics: Alanine Transaminase; Chronic Disease; Female; gamma-Glutamyltransferase; Hepatitis C; Humans; Male; Ursodeoxycholic Acid | 1993 |
Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.
Topics: Adult; Chi-Square Distribution; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Statistics, Nonparametric; Ursodeoxycholic Acid | 1996 |
Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum gamma-glutamyltranspeptidase levels.
Topics: Administration, Oral; Adult; Aged; Cholagogues and Choleretics; Chronic Disease; Female; gamma-Glutamyltransferase; Hepatitis C; Humans; Linear Models; Liver; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 1996 |
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Topics: Alkaline Phosphatase; Bile Acids and Salts; Cholestasis; Chronic Disease; Down-Regulation; Female; gamma-Glutamyltransferase; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis; Male; Middle Aged; Selenium Radioisotopes; Taurocholic Acid; Up-Regulation; Ursodeoxycholic Acid | 1996 |
Efficacy of ursodeoxycholic acid in combination with interferon-alpha in treating chronic hepatitis C: results of a long-term follow-up trial.
Topics: Alanine Transaminase; Antiviral Agents; Cholagogues and Choleretics; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; RNA, Viral; Ursodeoxycholic Acid; Viremia | 1996 |
Interferon plus ursodeoxycholic acid versus interferon in the treatment of chronic C viral hepatitis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cholagogues and Choleretics; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Recombinant Proteins; Recurrence; Ursodeoxycholic Acid | 1997 |
[Effects of therapy with bis-hemisuccinate of ursodeoxycholic acid bisodium salt in patients with chronic hepatitis].
Topics: Alkaline Phosphatase; Chronic Disease; Clinical Enzyme Tests; Female; gamma-Glutamyltransferase; Hepatitis; Humans; Liver Function Tests; Male; Placebos; Time Factors; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver.
Topics: Bilirubin; Cholestasis; Chronic Disease; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
Topics: Bile Acids and Salts; Cell Membrane; Cholestasis, Intrahepatic; Chronic Disease; Hepatitis, Chronic; Humans; In Vitro Techniques; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1992 |
Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases.
Topics: Animals; Cholestasis; Chronic Disease; Histocompatibility Antigens Class I; Humans; In Vitro Techniques; Liver Cirrhosis, Biliary; Major Histocompatibility Complex; Ursodeoxycholic Acid | 1991 |
Ursodeoxycholic acid for chronic liver diseases.
Topics: Chronic Disease; Clinical Trials as Topic; Deoxycholic Acid; Hepatitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1988 |
54 other study(ies) available for ursodeoxycholic acid and Chronic Disease
Article | Year |
---|---|
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.
Topics: Adult; Aged; Alkaline Phosphatase; Cholagogues and Choleretics; Chronic Disease; Databases, Factual; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Numbers Needed To Treat; Proportional Hazards Models; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Anatomy variant symptomatic of the duplication of the common bile duct type IV.
Topics: Aged, 80 and over; Balloon Embolectomy; Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Cholecystitis; Chronic Disease; Combined Modality Therapy; Common Bile Duct; Female; Hepatic Duct, Common; Humans; Magnetic Resonance Imaging; Prostheses and Implants; Sphincterotomy, Endoscopic; Tomography, X-Ray Computed; Ursodeoxycholic Acid | 2020 |
Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease.
Topics: beta Carotene; Child; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Diagnosis, Differential; Humans; Male; Photosensitivity Disorders; Protoporphyria, Erythropoietic; Provitamins; Pruritus; Ursodeoxycholic Acid | 2018 |
How best to manage chronic cholestasis.
Topics: Adult; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Disease Management; Family Practice; Female; Humans; Practice Guidelines as Topic; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Topics: 1-Naphthylisothiocyanate; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cell Proliferation; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Liver; Male; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley; Tretinoin; Ursodeoxycholic Acid | 2014 |
Facial lesions heralding the onset and relapse of eosinophilic fasciitis.
Topics: Adult; Arthritis; Biopsy; Chronic Disease; Colchicine; Edema; Eosinophilia; Fascia; Fasciitis; Folic Acid; Humans; Male; Myalgia; Prednisone; Recurrence; Synovitis; Ursodeoxycholic Acid; Vitamin E; West Indies | 2016 |
Chronic Pruritus in an 18-Month-Old Male Infant Due to Anicteric Cholestasis.
Topics: ATP Binding Cassette Transporter, Subfamily B; Biopsy; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Humans; Infant; Liver; Male; Pruritus; Treatment Outcome; Ursodeoxycholic Acid | 2017 |
Management of autoimmune and cholestatic liver disorders.
Topics: Anti-Inflammatory Agents; Azathioprine; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangitis, Sclerosing; Chronic Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Neoplasms; Liver Transplantation; Practice Guidelines as Topic; Prednisone; Ursodeoxycholic Acid | 2009 |
Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
Topics: Child; Child, Preschool; Cholagogues and Choleretics; Chronic Disease; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infant; Italy; Liver Diseases; Male; Morbidity; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
Pharmacotherapy of cholestatic liver diseases.
Topics: Bile; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Humans; Liver; Ursodeoxycholic Acid | 2010 |
Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Austria; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Chronic Disease; Female; Humans; Male; Middle Aged; Pruritus; Retrospective Studies; Risk Factors; Treatment Outcome; Up-Regulation; Ursodeoxycholic Acid | 2011 |
[Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
Topics: Bilirubin; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis, Intrahepatic; Chronic Disease; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Prognosis; S-Adenosylmethionine; Ursodeoxycholic Acid | 2011 |
[Intrahepatic cholestasis in chronic liver diseases].
Topics: Blood Coagulation; Cholestasis, Intrahepatic; Chronic Disease; Drug Therapy, Combination; Humans; Liver Diseases; Liver Function Tests; Prognosis; Quality of Life; S-Adenosylmethionine; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid | 2011 |
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bile Acids and Salts; Cell Proliferation; Cholestasis, Intrahepatic; Chronic Disease; Dietary Fats; Disease Models, Animal; Disease Progression; Fatty Acids; Female; Fenofibrate; Gene Expression Profiling; Gene Expression Regulation; Hepatitis; Hypolipidemic Agents; Lipid Metabolism; Liver; Liver Cirrhosis; Metabolomics; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Triglycerides; Ursodeoxycholic Acid | 2012 |
Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
Topics: Asian People; ATP Binding Cassette Transporter, Subfamily B; Bile Acids and Salts; Child, Preschool; China; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Female; gamma-Glutamyltransferase; Growth; Heterozygote; Humans; Infant; Infant, Newborn; Male; Mutation; Organ Size; Platelet Count; Pruritus; Spleen; Ursodeoxycholic Acid | 2012 |
Ursodeoxycholic acid: increased mortality.
Topics: Cholagogues and Choleretics; Cholestasis; Chronic Disease; Digestive System Diseases; Drug Administration Schedule; Evidence-Based Medicine; Humans; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Autoimmune pancreatitis successfully treated with ursodeoxycholic acid.
Topics: Angiography; Autoimmune Diseases; Biopsy, Needle; Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; Female; Hematologic Tests; Humans; Immunologic Tests; Magnetic Resonance Imaging; Middle Aged; Pancreas; Pancreatitis; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2002 |
Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.
Topics: Animals; Cardiolipins; Cholestasis; Chronic Disease; Cystathionine gamma-Lyase; Glutamate-Cysteine Ligase; Glutathione; Hepatocytes; Liver; Liver Cirrhosis, Biliary; Male; Membrane Potentials; Mitochondria; Oxidation-Reduction; Oxidative Stress; Peroxides; Rats; Rats, Wistar; Ursodeoxycholic Acid | 2004 |
[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Hypercholesterolemia; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
Gamma-glutamyltransferase decreases in patients with the chronic form of schistosomiasis mansoni treated with ursodeoxycholic acid.
Topics: Adult; Chronic Disease; Female; gamma-Glutamyltransferase; Humans; Male; Prospective Studies; Schistosomiasis mansoni; Ursodeoxycholic Acid | 2005 |
Portal-systemic spill-over of bile acids: a study of mechanisms using ursodeoxycholic acid.
Topics: Adult; Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Female; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1983 |
[Hepatology in 1981].
Topics: Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholelithiasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Peliosis Hepatis; Peritoneovenous Shunt; Ursodeoxycholic Acid | 1981 |
[Features and therapy of the patients with chronic hepatitis C resistant to IFN therapy].
Topics: Antiviral Agents; Chronic Disease; Drug Resistance; Hepatitis C; Humans; Interferons; Treatment Outcome; Ursodeoxycholic Acid | 1995 |
Ursodeoxycholic acid for chronic hepatitis C patients.
Topics: Alanine Transaminase; Chronic Disease; Hepatitis C; Humans; Ursodeoxycholic Acid | 1995 |
[Measurement of bile acid N-acetylglucosaminides in serum and urine of patients with chronic liver diseases during ursodeoxycholic acid treatment].
Topics: Acetylglucosamine; Bile Acids and Salts; Chronic Disease; Humans; Liver Diseases; Middle Aged; Ursodeoxycholic Acid | 1995 |
Clinicopathological study of proliferating cell nuclear antigen (PCNA) of hepatocytes in primary biliary cirrhosis.
Topics: Chronic Disease; DNA; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Ursodeoxycholic Acid | 1994 |
[Biliary scintigraphy. Application to the study of chronic cholestasis].
Topics: Aged; Aged, 80 and over; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Indocyanine Green; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Sulfobromophthalein; Ursodeoxycholic Acid | 1993 |
Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver disease under ursodeoxycholic acid therapy.
Topics: Adult; Aged; Bile Acids and Salts; Cholangitis, Sclerosing; Chronic Disease; Dietary Fiber; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Psyllium; Ursodeoxycholic Acid | 1995 |
Eosinophilia in primary biliary cirrhosis.
Topics: Aged; Chronic Disease; Eosinophilia; Eosinophils; Female; Flow Cytometry; Humans; Leukocyte Count; Liver Cirrhosis, Biliary; Male; Middle Aged; Prevalence; Ursodeoxycholic Acid | 1996 |
Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C.
Topics: Chronic Disease; Hepacivirus; Hepatitis C; Humans; Ursodeoxycholic Acid; Virus Replication | 1996 |
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1996 |
Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
Topics: Adult; Aged; Bile Acids and Salts; Chronic Disease; Female; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Sulfates; Ursodeoxycholic Acid | 1996 |
Low prevalence of alterations in the pancreatic duct system in patients with primary sclerosing cholangitis.
Topics: Adult; Bile Ducts; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Ethanol; Female; Follow-Up Studies; Humans; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Prevalence; Retrospective Studies; Risk Factors; Ursodeoxycholic Acid | 1996 |
Sjögren's syndrome with chronic pancreatitis, sclerosing cholangitis, and pulmonary infiltrations.
Topics: Adult; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Chronic Disease; Humans; Lung Diseases; Male; Pancreatitis; Sjogren's Syndrome; Ursodeoxycholic Acid | 1997 |
Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dose-Response Relationship, Drug; Enteritis; Indomethacin; Intestinal Mucosa; Male; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid | 1997 |
Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Liver; Liver Diseases; Middle Aged; Sarcoidosis; Ursodeoxycholic Acid | 1997 |
[Primary sclerosing cholangitis with chronic pancreatitis].
Topics: Aged; Cholagogues and Choleretics; Cholangitis, Sclerosing; Chronic Disease; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Insulin; Male; Pancreatic Hormones; Pancreatitis; Ursodeoxycholic Acid | 1997 |
[Unusual diagnosis in recurrent arthritis, erythema nodosum and arrhythmia].
Topics: Adult; Arrhythmias, Cardiac; Arthritis; Biopsy; Cholangitis; Chronic Disease; Diagnosis, Differential; Erythema Nodosum; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Recurrence; Time Factors; Tomography, X-Ray Computed; Ursodeoxycholic Acid | 1997 |
Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
Topics: Adult; Bile Acids and Salts; Cholestasis, Intrahepatic; Cholestenones; Cholestyramine Resin; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Fasting; Female; Humans; Male; Pruritus; Ursodeoxycholic Acid | 2000 |
The chronic disease of childhood obesity: the sleeping giant has awakened.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child; Chronic Disease; Fatty Liver; Health Promotion; Humans; Life Style; Liver Diseases; Obesity; Ursodeoxycholic Acid | 2000 |
Hepatic hydroxylation of bile acids and chronic liver diseases: do transporters play a mechanistic role?
Topics: Bile Acids and Salts; Biliary Tract Diseases; Carrier Proteins; Chronic Disease; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Humans; Hydroxylation; Liver; Liver Diseases; Membrane Transport Proteins; Organic Anion Transporters, Sodium-Dependent; Symporters; Ursodeoxycholic Acid | 2001 |
Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.
Topics: Chronic Disease; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Silymarin; Ursodeoxycholic Acid | 1992 |
Clinical evidence of hepatoprotection induced by ursodeoxycholic acid.
Topics: Aged; Bilirubin; Cholestasis, Intrahepatic; Chronic Disease; Hepatitis Antibodies; Hepatitis C; Humans; Liver Function Tests; Male; Prednisolone; Ursodeoxycholic Acid | 1992 |
Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis.
Topics: 5'-Nucleotidase; Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Bilirubin; Child; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Ursodeoxycholic Acid | 1992 |
[Factors influencing the effect of ursodeoxycholic acid therapy in chronic hypertransaminasemia].
Topics: Adult; Aged; Chronic Disease; Clinical Enzyme Tests; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Middle Aged; Regression Analysis; Transaminases; Ursodeoxycholic Acid | 1992 |
Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease.
Topics: Adult; Bile Acids and Salts; Cholangitis, Sclerosing; Chronic Disease; Female; Humans; Kinetics; Liver Cirrhosis, Biliary; Male; Middle Aged; Reference Values; Ursodeoxycholic Acid | 1992 |
Lithocholic acid accumulation.
Topics: Animals; Chronic Disease; Humans; Lithocholic Acid; Liver; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Lipoprotein (a) serum levels in chronic cholestatic liver disease during treatment with ursodeoxycholic acid.
Topics: Cholestasis; Chronic Disease; Humans; Lipoproteins; Ursodeoxycholic Acid | 1991 |
Lipoprotein (a) serum levels in chronic cholestatic liver disease during treatment with ursodeoxycholic acid.
Topics: Adult; Arteriosclerosis; Cholestasis, Intrahepatic; Chronic Disease; Deoxycholic Acid; Female; Humans; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Risk Factors; Ursodeoxycholic Acid | 1990 |
Ursodeoxycholic acid therapy in chronic active hepatitis.
Topics: Adult; Autoimmune Diseases; Azathioprine; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis, Chronic; Humans; Prednisolone; Ursodeoxycholic Acid | 1990 |
Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.
Topics: Adolescent; Adult; Child; Cholestasis; Chronic Disease; Cystic Fibrosis; Deoxycholic Acid; Female; Humans; Liver; Liver Function Tests; Male; Nutritional Status; Prospective Studies; Ursodeoxycholic Acid | 1990 |
[The influence of ursodeoxycholic acid on hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases].
Topics: Adult; Biliary Tract; Chronic Disease; Deoxycholic Acid; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pyridoxal; Radionuclide Imaging; Tryptophan; Ursodeoxycholic Acid | 1988 |
[Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
Topics: Bile Acids and Salts; Chronic Disease; Deoxycholic Acid; Glucagon; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Predictive Value of Tests; Ursodeoxycholic Acid | 1988 |
[Bile acids in chronic hepatopathies].
Topics: Adult; Bile Acids and Salts; Cholestasis; Chronic Disease; Diagnosis, Differential; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Middle Aged; Ursodeoxycholic Acid | 1986 |